{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:05:57Z","timestamp":1789113957017,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574440"],"award-info":[{"award-number":["82574440"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32301063"],"award-info":[{"award-number":["32301063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515030270"],"award-info":[{"award-number":["2024A1515030270"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010598"],"award-info":[{"award-number":["2023A1515010598"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012243","name":"Foundation for Distinguished Young Talents in Higher Education of Guangdong","doi-asserted-by":"publisher","award":["2024ZDZX2052"],"award-info":[{"award-number":["2024ZDZX2052"]}],"id":[{"id":"10.13039\/501100012243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["for zhangpeng"],"award-info":[{"award-number":["for zhangpeng"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Prod. Bioprospect."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s13659-026-00645-9","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:11:57Z","timestamp":1789110717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A fungal-derived benzothiazole derivative overcomes osimertinib resistance in NSCLC by targeting SCD1"],"prefix":"10.1007","volume":"16","author":[{"given":"Boyin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiudi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2075-0461","authenticated-orcid":false,"given":"Xueping","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"1","key":"645_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"645_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","volume":"19","author":"AJ Cooper","year":"2022","unstructured":"Cooper AJ, Sequist LV, Lin JJ. Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management. Nat Rev Clin Oncol. 2022;19(8):499\u2013514. https:\/\/doi.org\/10.1038\/s41571-022-00639-9.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"645_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s43018-021-00195-8","volume":"2","author":"A Passaro","year":"2021","unstructured":"Passaro A, J\u00e4nne PA, Mok T, et al. Overcoming therapy resistance in EGFR-mutant lung cancer. Nat Cancer. 2021;2(4):377\u201391. https:\/\/doi.org\/10.1038\/s43018-021-00195-8.","journal-title":"Nat Cancer."},{"key":"645_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102557","volume":"116","author":"Z Zalaquett","year":"2023","unstructured":"Zalaquett Z, Catherine Rita Hachem M, Kassis Y, et al. Acquired resistance mechanisms to osimertinib: The constant battle. Cancer Treat Rev. 2023;116:102557. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102557.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"645_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-022-01391-4","volume":"15","author":"K Fu","year":"2022","unstructured":"Fu K, Xie F, Wang F, et al. Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance. J Hematol Oncol. 2022;15(1):173. https:\/\/doi.org\/10.1186\/s13045-022-01391-4.","journal-title":"J Hematol Oncol"},{"issue":"18","key":"645_CR6","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","volume":"383","author":"YL Wu","year":"2020","unstructured":"Wu YL, Tsuboi M, He J, et al. Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N Engl J Med. 2020;383(18):1711\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2027071.","journal-title":"N Engl J Med"},{"issue":"18","key":"645_CR7","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1158\/1078-0432.CCR-22-1912","volume":"29","author":"JB Blaquier","year":"2023","unstructured":"Blaquier JB, Ortiz-Cuaran S, Ricciuti B, et al. Tackling osimertinib resistance in EGFR-mutant non-small cell lung cancer. Clin Cancer Res. 2023;29(18):3579\u201391. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1912.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"645_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1021\/acs.jmedchem.1c00876","volume":"65","author":"M Shaikh","year":"2022","unstructured":"Shaikh M, Shinde Y, Pawara R, et al. Emerging approaches to overcome acquired drug resistance obstacles to osimertinib in non-small-cell lung cancer. J Med Chem. 2022;65(2):1008\u201346. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00876.","journal-title":"J Med Chem"},{"key":"645_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105583","volume":"167","author":"RF Dong","year":"2021","unstructured":"Dong RF, Zhu ML, Liu MM, et al. EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research. Pharmacol Res. 2021;167:105583. https:\/\/doi.org\/10.1016\/j.phrs.2021.105583.","journal-title":"Pharmacol Res"},{"issue":"16","key":"645_CR10","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1056\/NEJMoa2403614","volume":"391","author":"BC Cho","year":"2024","unstructured":"Cho BC, Lu S, Felip E, et al. Amivantamab plus lazertinib in previously untreated EGFR-mutated advanced NSCLC. N Engl J Med. 2024;391(16):1486\u201398. https:\/\/doi.org\/10.1056\/NEJMoa2403614.","journal-title":"N Engl J Med"},{"issue":"8023","key":"645_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41586-024-07530-w","volume":"632","author":"K Lewis","year":"2024","unstructured":"Lewis K, Lee RE, Br\u00f6tz-Oesterhelt H, et al. Sophisticated natural products as antibiotics. Nature. 2024;632(8023):39\u201349. https:\/\/doi.org\/10.1038\/s41586-024-07530-w.","journal-title":"Nature"},{"key":"645_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.107034","volume":"199","author":"W Tian","year":"2024","unstructured":"Tian W, Huang J, Zhang W, et al. Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism. Pharmacol Res. 2024;199:107034. https:\/\/doi.org\/10.1016\/j.phrs.2023.107034.","journal-title":"Pharmacol Res"},{"key":"645_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108752","volume":"264","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang F, Liu W, et al. New drug discovery and development from natural products: advances and strategies. Pharmacol Ther. 2024;264:108752. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108752.","journal-title":"Pharmacol Ther"},{"issue":"50","key":"645_CR14","doi-asserted-by":"publisher","first-page":"27939","DOI":"10.1021\/acs.jafc.4c07702","volume":"72","author":"XL Yuan","year":"2024","unstructured":"Yuan XL, Zhao DL, Zhang ZF, et al. Characterization of a new insecticidal benzothiazole derivative from Aspergillus sp. 1022LEF against the fall armyworm, Spodoptera frugiperda (Lepidoptera: Noctuidae). J Agric Food Chem. 2024;72(50):27939\u201352. https:\/\/doi.org\/10.1021\/acs.jafc.4c07702.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"645_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58499-5","volume":"14","author":"S Lv","year":"2024","unstructured":"Lv S, Pan Q, Lu W, et al. Tenovin 3 induces apoptosis and ferroptosis in EGFR 19del non small cell lung cancer cells. Sci Rep. 2024;14(1):7654. https:\/\/doi.org\/10.1038\/s41598-024-58499-5.","journal-title":"Sci Rep"},{"issue":"10","key":"645_CR16","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1016\/j.apsb.2022.05.024","volume":"12","author":"X Lei","year":"2022","unstructured":"Lei X, Li Z, Zhong Y, et al. Gli1 promotes epithelial-mesenchymal transition and metastasis of non-small cell lung carcinoma by regulating snail transcriptional activity and stability. Acta Pharm Sin B. 2022;12(10):3877\u201390. https:\/\/doi.org\/10.1016\/j.apsb.2022.05.024.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"645_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJMoa2304594","volume":"389","author":"M Tsuboi","year":"2023","unstructured":"Tsuboi M, Herbst RS, John T, et al. Overall survival with Osimertinib in resected EGFR-mutated NSCLC. N Engl J Med. 2023;389(2):137\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2304594.","journal-title":"N Engl J Med"},{"issue":"1","key":"645_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34889-z","volume":"13","author":"SJ Adua","year":"2022","unstructured":"Adua SJ, Arnal-Estap\u00e9 A, Zhao M, et al. Brain metastatic outgrowth and Osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Nat Commun. 2022;13(1):7690. https:\/\/doi.org\/10.1038\/s41467-022-34889-z.","journal-title":"Nat Commun"},{"issue":"1","key":"645_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41416-023-02475-9","volume":"130","author":"A Leonetti","year":"2024","unstructured":"Leonetti A, Verz\u00e8 M, Minari R, et al. Resistance to Osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies. Br J Cancer. 2024;130(1):135\u201342. https:\/\/doi.org\/10.1038\/s41416-023-02475-9.","journal-title":"Br J Cancer"},{"issue":"2","key":"645_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li D, Wang Y, Dong C, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023;42(2):83\u201398. https:\/\/doi.org\/10.1038\/s41388-022-02537-x.","journal-title":"Oncogene"},{"issue":"4","key":"645_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","volume":"5","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu J, Cheng Q, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024;5(4):572\u201389. https:\/\/doi.org\/10.1038\/s43018-023-00715-8.","journal-title":"Nat Cancer"},{"issue":"4","key":"645_CR22","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.7150\/ijbs.79853","volume":"19","author":"Q Wang","year":"2023","unstructured":"Wang Q, Gao S, Shou Y, et al. AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis. Int J Biol Sci. 2023;19(4):1266\u201383. https:\/\/doi.org\/10.7150\/ijbs.79853.","journal-title":"Int J Biol Sci"},{"key":"645_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103035","volume":"70","author":"M Shen","year":"2024","unstructured":"Shen M, Cao S, Long X, et al. DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT. Redox Biol. 2024;70:103035. https:\/\/doi.org\/10.1016\/j.redox.2024.103035.","journal-title":"Redox Biol"},{"key":"645_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106739","volume":"191","author":"C Xu","year":"2023","unstructured":"Xu C, Jiang ZB, Shao L, et al. \u03b2-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer. Pharmacol Res. 2023;191:106739. https:\/\/doi.org\/10.1016\/j.phrs.2023.106739.","journal-title":"Pharmacol Res"},{"key":"645_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, et al. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 2023;66:100916. https:\/\/doi.org\/10.1016\/j.drup.2022.100916.","journal-title":"Drug Resist Updat"},{"issue":"22","key":"645_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300322","volume":"18","author":"Y Batsi","year":"2023","unstructured":"Batsi Y, Antonopoulou G, Fotopoulou T, et al. Design and synthesis of novel 2-Acetamido, 6-Carboxamide substituted benzothiazoles as potential BRAFV600E inhibitors - in vitro evaluation of their antiproliferative activity. ChemMedChem. 2023;18(22):e202300322. https:\/\/doi.org\/10.1002\/cmdc.202300322.","journal-title":"ChemMedChem"},{"issue":"7","key":"645_CR27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2174\/1570179419666220330001036","volume":"19","author":"AH Kurt","year":"2022","unstructured":"Kurt AH, Ayaz L, Ayaz F, et al. A review on the design, synthesis, and structure-activity relationships of benzothiazole derivatives against hypoxic tumors. Curr Org Synth. 2022;19(7):772\u201396. https:\/\/doi.org\/10.2174\/1570179419666220330001036.","journal-title":"Curr Org Synth"},{"issue":"12","key":"645_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202100246","volume":"354","author":"K Haider","year":"2021","unstructured":"Haider K, Rehman S, Pathak A, et al. Advances in 2-substituted benzothiazole scaffold-based chemotherapeutic agents. Arch Pharm (Weinheim). 2021;354(12):e2100246. https:\/\/doi.org\/10.1002\/ardp.202100246.","journal-title":"Arch Pharm (Weinheim)"},{"key":"645_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114333","volume":"236","author":"L Zha","year":"2022","unstructured":"Zha L, Xie Y, Wu C, et al. Novel benzothiazole\u2012urea hybrids: design, synthesis and biological activity as potent anti-bacterial agents against MRSA. Eur J Med Chem. 2022;236:114333. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114333.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"645_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202300493","volume":"357","author":"P Kamboj","year":"2024","unstructured":"Kamboj P, Mahore A, Husain A, et al. Benzothiazole-based apoptosis inducers: a comprehensive overview and future prospective. Arch Pharm (Weinheim). 2024;357(4):e2300493. https:\/\/doi.org\/10.1002\/ardp.202300493.","journal-title":"Arch Pharm (Weinheim)"},{"issue":"7","key":"645_CR31","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.7150\/thno.70194","volume":"12","author":"Y Xuan","year":"2022","unstructured":"Xuan Y, Wang H, Yung MM, et al. SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells. Theranostics. 2022;12(7):3534\u201352. https:\/\/doi.org\/10.7150\/thno.70194.","journal-title":"Theranostics"},{"key":"645_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.canlet.2017.07.027","volume":"406","author":"ME Pisanu","year":"2017","unstructured":"Pisanu ME, Noto A, De Vitis C, et al. Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells. Cancer Lett. 2017;406:93\u2013104. https:\/\/doi.org\/10.1016\/j.canlet.2017.07.027.","journal-title":"Cancer Lett"},{"issue":"1","key":"645_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38581-8","volume":"14","author":"TL Wong","year":"2023","unstructured":"Wong TL, Loh JJ, Lu S, et al. ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. Nat Commun. 2023;14(1):2861. https:\/\/doi.org\/10.1038\/s41467-023-38581-8.","journal-title":"Nat Commun"},{"issue":"7","key":"645_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004616","volume":"10","author":"Y Katoh","year":"2022","unstructured":"Katoh Y, Yaguchi T, Kubo A, et al. Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating \u03b2-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody. J Immunother Cancer. 2022;10(7):e004616. https:\/\/doi.org\/10.1136\/jitc-2022-004616.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"645_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1057-7","volume":"38","author":"J Zhou","year":"2019","unstructured":"Zhou J, Qu G, Zhang G, et al. Glycerol kinase 5 confers gefitinib resistance through SREBP1\/SCD1 signaling pathway. J Exp Clin Cancer Res. 2019;38(1):96. https:\/\/doi.org\/10.1186\/s13046-019-1057-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"13","key":"645_CR36","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1158\/0008-5472.CAN-24-2745","volume":"85","author":"U Sen","year":"2025","unstructured":"Sen U, Coleman C, Gandhi N, et al. SCD1 Inhibition blocks the AKT-NRF2-SLC7A11 pathway to induce lipid metabolism remodeling and ferroptosis priming in lung adenocarcinoma. Cancer Res. 2025;85(13):2485\u2013503. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-2745.","journal-title":"Cancer Res"},{"key":"645_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jare.2024.09.027","volume":"74","author":"G Huang","year":"2025","unstructured":"Huang G, Cai Y, Ren M, et al. Salidroside sensitizes triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy. J Adv Res. 2025;74:589\u2013607. https:\/\/doi.org\/10.1016\/j.jare.2024.09.027.","journal-title":"J Adv Res"},{"key":"645_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102006","volume":"43","author":"G Luis","year":"2021","unstructured":"Luis G, Godfroid A, Nishiumi S, et al. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biol. 2021;43:102006. https:\/\/doi.org\/10.1016\/j.redox.2021.102006.","journal-title":"Redox Biol"}],"container-title":["Natural Products and Bioprospecting"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-026-00645-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13659-026-00645-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-026-00645-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:11:59Z","timestamp":1789110719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13659-026-00645-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1007\/s13659-026-00645-9","relation":{},"ISSN":["2192-2195","2192-2209"],"issn-type":[{"value":"2192-2195","type":"print"},{"value":"2192-2209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the animal experiments were conducted under the supervision of the Laboratory Animal Ethics Committee of Guangzhou Medical University and it complies with ARRIVE guidelines (reference number: S2022-305). Informed consent was obtained from NSCLC patients and the study was approved by the ethical committee of the Sixth Affiliated Hospital of Guangzhou Medical University (IRB-2021-025).","order":1,"name":"Ethics","label":"Ethics approval and consent participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could affect the work reported here.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"86"}}